HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Scott Pearsall Selected Research

R Scott Pearsall Research Topics

Disease

3Pulmonary Arterial Hypertension
12/2022 - 11/2016
3Neoplasms (Cancer)
07/2016 - 10/2004
2Pulmonary Hypertension
01/2020 - 11/2016
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2005
2Osteogenesis Imperfecta (Lobstein Disease)
10/2018 - 01/2018
2Anemia
06/2014 - 04/2014
2Osteoporosis
06/2012 - 04/2010
2Bone Resorption
06/2012 - 04/2010
1Inflammation (Inflammations)
12/2022
1Muscle Weakness
01/2021
1Vascular Diseases (Vascular Disease)
01/2020
1Neuromuscular Diseases (Neuromuscular Disease)
01/2019
1Congenital Abnormalities (Deformity)
11/2018
1Hypoxia (Hypoxemia)
11/2016
1Vascular Remodeling
11/2016
1Necrosis
07/2016
1Renal Cell Carcinoma (Grawitz Tumor)
07/2016
1Hypertrophy
01/2016
1Breast Neoplasms (Breast Cancer)
06/2015
1Carcinoma (Carcinomatosis)
06/2015
1Neoplasm Metastasis (Metastasis)
06/2015
1beta-Thalassemia (Cooley's Anemia)
06/2014
1Splenomegaly
06/2014
1Thalassemia
06/2014
1Hemolysis
06/2014
1Iron Overload
06/2014
1Hyperplasia
04/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2014
1Pre-Eclampsia (Preeclampsia)
08/2011
1Hereditary Hemorrhagic Telangiectasia
08/2011
1Carcinogenesis
12/2005
1Herpes Zoster
02/2005

Drug/Important Bio-Agent (IBA)

6Activins (Activin)IBA
12/2022 - 06/2015
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 04/2014
4LigandsIBA
01/2019 - 04/2014
3activin receptor type II-BIBA
10/2018 - 06/2014
2ACE-011IBA
12/2022 - 04/2010
2Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2010
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2020 - 08/2011
2AzoxymethaneIBA
01/2020 - 12/2005
2FollistatinIBA
01/2019 - 11/2018
2Phosphotransferases (Kinase)IBA
11/2016 - 06/2015
2ErythropoietinFDA Link
06/2014 - 04/2014
2luspaterceptIBA
06/2014 - 04/2014
2Activin Receptors (Activin Receptor)IBA
06/2014 - 06/2012
1Growth Differentiation FactorsIBA
12/2022
1activin receptor type II-A (activin A receptor, type II)IBA
12/2022
1DystrophinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1activin AIBA
01/2020
1Glycoproteins (Glycoprotein)IBA
01/2019
1Collagen Type I (Type I Collagen)IBA
10/2018
1alpha2 Subunit Collagen Type IIBA
10/2018
1MonocrotalineIBA
11/2016
1Semaxinib (SU5416)IBA
11/2016
1Plasminogen Activators (Plasminogen Activator)IBA
11/2016
1human ALK1-Fc fusion proteinIBA
07/2016
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2016
1Sunitinib (Sutent)FDA Link
07/2016
1MyostatinIBA
01/2016
1IronIBA
06/2014
1GlobinsIBA
06/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2014
1Bone Density Conservation AgentsIBA
06/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2011
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2011
1EndoglinIBA
08/2011
1Transforming Growth Factor alpha (TGF-alpha)IBA
02/2005
1Epidermal Growth Factor (EGF)IBA
10/2004
1Dextran SulfateIBA
10/2004
1EpiregulinIBA
10/2004

Therapy/Procedure

2Therapeutics
01/2021 - 06/2012
1Intramuscular Injections
11/2018
1Drug Therapy (Chemotherapy)
06/2015
1Diet Therapy (Therapy, Diet)
12/2005
1Oral Administration
10/2004